February, 2011 – FutureChemistry has joined a research project ‘UltraSenseNMR’ together with two Dutch universities and two SME companies, funded by the European Union. In the project, ultrasensitive NMR technology will be combined with FutureChemistry’s unique expertise on microreactors and flow processes, ultimately leading to new possibilities for the early stage medical diagnosis of e.g. prostate carcinomae.
0 Comments